110 related articles for article (PubMed ID: 11092491)
1. Staging uterine cervical carcinoma with low-field MR imaging.
Hansen MA; Pedersen PH; Andreasson B; Bjerregaard B; Thomsen HS
Acta Radiol; 2000 Nov; 41(6):647-52. PubMed ID: 11092491
[TBL] [Abstract][Full Text] [Related]
2. Fast dynamic contrast enhanced MR imaging of cervical carcinoma.
Van Vierzen PB; Massuger LF; Ruys SH; Barentsz JO
Clin Radiol; 1998 Mar; 53(3):183-92. PubMed ID: 9528868
[TBL] [Abstract][Full Text] [Related]
3. Cervical carcinoma: comparison of standard and pharmacokinetic MR imaging.
Hawighorst H; Knapstein PG; Weikel W; Knopp MV; Schaeffer U; Brix G; Essig M; Hoffmann U; Zuna I; Schönberg S; van Kaick G
Radiology; 1996 Nov; 201(2):531-9. PubMed ID: 8888254
[TBL] [Abstract][Full Text] [Related]
4. CT and ultra low field (0.02 T) MR imaging of uterine cervical carcinoma.
Varpula M; Kilholma P; Klemi P
Acta Radiol; 1994 Jul; 35(4):361-6. PubMed ID: 8011386
[TBL] [Abstract][Full Text] [Related]
5. Dynamic contrast-enhanced MR imaging of uterine cervical cancer: pharmacokinetic analysis with histopathologic correlation and its importance in predicting the outcome of radiation therapy.
Yamashita Y; Baba T; Baba Y; Nishimura R; Ikeda S; Takahashi M; Ohtake H; Okamura H
Radiology; 2000 Sep; 216(3):803-9. PubMed ID: 10966715
[TBL] [Abstract][Full Text] [Related]
6. Invasive adenocarcinoma of the uterine cervix: MR imaging.
Torashima M; Yamashita Y; Hatanaka Y; Takahashi M; Miyazaki K; Okamura H
Comput Med Imaging Graph; 1997; 21(4):253-60. PubMed ID: 9402238
[TBL] [Abstract][Full Text] [Related]
7. Carcinoma of the cervix: value of plain and gadolinium-enhanced MR imaging in assessing degree of invasiveness.
Sironi S; De Cobelli F; Scarfone G; Colombo E; Bolis G; Ferrari A; DelMaschio A
Radiology; 1993 Sep; 188(3):797-801. PubMed ID: 8351350
[TBL] [Abstract][Full Text] [Related]
8. Stromal invasion by carcinoma of the cervix: assessment with dynamic MR imaging.
Seki H; Azumi R; Kimura M; Sakai K
AJR Am J Roentgenol; 1997 Jun; 168(6):1579-85. PubMed ID: 9168730
[TBL] [Abstract][Full Text] [Related]
9. Preliminary experience with gadolinium-enhanced dynamic MR imaging for uterine neoplasms.
Hirano Y; Kubo K; Hirai Y; Okada S; Yamada K; Sawano S; Yamashita T; Hiramatsu Y
Radiographics; 1992 Mar; 12(2):243-56. PubMed ID: 1561414
[TBL] [Abstract][Full Text] [Related]
10. Pelvic lesions in patients with treated cervical carcinoma: efficacy of pharmacokinetic analysis of dynamic MR images in distinguishing recurrent tumors from benign conditions.
Hawighorst H; Knapstein PG; Schaeffer U; Knopp MV; Brix G; Hoffmann U; Zuna I; Essig M; van Kaick G
AJR Am J Roentgenol; 1996 Feb; 166(2):401-8. PubMed ID: 8553955
[TBL] [Abstract][Full Text] [Related]
11. Comparison of T2-weighted and contrast-enhanced T1-weighted MR imaging at 1.5 T for assessing the local extent of cervical carcinoma.
Akita A; Shinmoto H; Hayashi S; Akita H; Fujii T; Mikami S; Tanimoto A; Kuribayashi S
Eur Radiol; 2011 Sep; 21(9):1850-7. PubMed ID: 21479769
[TBL] [Abstract][Full Text] [Related]
12. MR imaging features and staging of neuroendocrine carcinomas of the uterine cervix with pathological correlations.
Duan X; Ban X; Zhang X; Hu H; Li G; Wang D; Wang CQ; Zhang F; Shen J
Eur Radiol; 2016 Dec; 26(12):4293-4302. PubMed ID: 26995208
[TBL] [Abstract][Full Text] [Related]
13. Carcinoma of the uterus: use of gadopentetate dimeglumine in MR imaging.
Hricak H; Hamm B; Semelka RC; Cann CE; Nauert T; Secaf E; Stern JL; Wolf KJ
Radiology; 1991 Oct; 181(1):95-106. PubMed ID: 1887062
[TBL] [Abstract][Full Text] [Related]
14. Staging of cervical carcinomas. Comparison of body-coil magnetic resonance imaging and endorectal surface coil magnetic resonance imaging with histopathologic correlation.
Preidler KW; Tamussino K; Szolar DM; Ranner G; Ebner F
Invest Radiol; 1996 Jul; 31(7):458-62. PubMed ID: 8818786
[TBL] [Abstract][Full Text] [Related]
15. High-resolution MR imaging of stage I cervical neoplasia with a dedicated transvaginal coil: MR features and correlation of imaging and pathologic findings.
deSouza NM; Scoones D; Krausz T; Gilderdale DJ; Soutter WP
AJR Am J Roentgenol; 1996 Mar; 166(3):553-9. PubMed ID: 8623627
[TBL] [Abstract][Full Text] [Related]
16. Rectal cancer: MR imaging in local staging--is gadolinium-based contrast material helpful?
Vliegen RF; Beets GL; von Meyenfeldt MF; Kessels AG; Lemaire EE; van Engelshoven JM; Beets-Tan RG
Radiology; 2005 Jan; 234(1):179-88. PubMed ID: 15550372
[TBL] [Abstract][Full Text] [Related]
17. Staging of rectal cancer by double-contrast MR imaging using the rectally administered superparamagnetic iron oxide contrast agent ferristene and IV gadodiamide injection: results of a multicenter phase II trial.
Maier AG; Kersting-Sommerhoff B; Reeders JW; Judmaier W; Schima W; Annweiler AA; Meusel M; Wallengren NO
J Magn Reson Imaging; 2000 Nov; 12(5):651-60. PubMed ID: 11050634
[TBL] [Abstract][Full Text] [Related]
18. [Parametrial infiltration of cervix carcinoma: diagnostic value of contrast-enhanced fat-suppressed T1-weighted SE sequences at 1.5 tesla].
Scheidler J; Heuck A; Wencke K; Kimmig R; Müller-Lisse U; Reiser M
Rofo; 1997 Apr; 166(4):312-6. PubMed ID: 9198495
[TBL] [Abstract][Full Text] [Related]
19. Parametrial invasion in cervical carcinoma: evaluation of detection at MR imaging with fat suppression.
Scheidler J; Heuck AF; Steinborn M; Kimmig R; Reiser MF
Radiology; 1998 Jan; 206(1):125-9. PubMed ID: 9423661
[TBL] [Abstract][Full Text] [Related]
20. [Lymph node staging in cervix carcinomas: the results of high-resolution magnetic resonance tomography (MRT) with a phased-array body coil].
Heuck A; Scheidler J; Kimmig R; Müller-Lisse U; Steinborn M; Helmberger T; Reiser M
Rofo; 1997 Mar; 166(3):210-4. PubMed ID: 9156591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
